International Clinical Trial: An Open-Label, Two-Part Study of the Safety, Tolerability, Efficacy, and Pharmacokinetics of RECCE(R)327 Topical Gel in Diabetic-Related Foot Infections: Part B - A Randomized, Active-Controlled, Non-Inferiority Study in Diabetic-related Foot Infections

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ACTRN12626001202358) titled 'An Open-Label, Two-Part Study of the Safety, Tolerability, Efficacy, and Pharmacokinetics of RECCE(R)327 Topical Gel in Diabetic-Related Foot Infections: Part B - A Randomized, Active-Controlled, Non-Inferiority Study in Diabetic-related Foot Infections' on Sept. 28.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Open (masking not used) Assignment: Parallel

Primary Sponsor: Recce Pharmaceuticals Limited

Condition: Diabetic Foot Infections, inclusive of lower leg ulcer infections below the knee Diabetic Foot Infections, inclusive of lower leg ulc...